Novo Nordisk
Novo Nordisk forms academic partnership with Washington Uni
November 4, 2015Research and Development Novo Nordisk, diabetes, obesity
Novo Nordisk has launched a new research collaboration with researchers at the University of Washington, to develop new drugs for …
Novo Nordisk posts strong nine-month results
October 29, 2015Sales and Marketing Novo Nordisk, insulin
Novo Nordisk has exceeded market expectations in its nine-month financial results, reporting a 51% increase in operating profit and 33% …
Novo chief executive ranked ‘world’s best’
October 14, 2015Medical Communications, Sales and Marketing Harvard Business Review, Lars Rebien Sorensen, Novo Nordisk
Novo Nordisk chief executive Lars Rebien Sørensen has been named the best-performing in the world by the Harvard Business Review. …
Novo Nordisk and Diabetes UK extend ‘Clinical Champions’ initiative
October 6, 2015Medical Communications Novo Nordisk, diabetes
Diabetes UK and Novo Nordisk have announced the appointment of 20 Diabetes UK ‘Clinical Champions’, who will be supported and …
Professor Stephen Gough joins Novo Nordisk as senior principal clinical scientist
October 2, 2015Medical Communications, Research and Development Novo Nordisk, Professor Stephen Gough
Novo Nordisk has announced that Professor Stephen Gough, a renowned clinical and research specialist in diabetes, joined the company today …
FDA approves Novo Nordisk’s diabetes drugs
September 28, 2015Sales and Marketing FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin
The FDA has approved two Novo Nordisk drugs, Tresiba and Ryzodeg, for the treatment of type 2 diabetes in adults.The …
Novo Nordisk to build manufacturing plant for FlexPen in Iran
September 22, 2015Manufacturing and Production Iran, Novo Nordisk, diabetes
Novo Nordisk has announced that Novo Nordisk Iran and the Food and Drug Administration of the Islamic Republic of Iran …
Working Life: Novo Nordisk’s Klaus Henning-Jensen
September 21, 2015Sales and Marketing Novo Nordisk, Working Life
How did you find your way into your current role?I started out in medicine at Bispebjerg, which is a large …
Novo Nordisk expands in Denmark
September 8, 2015Manufacturing and Production, Research and Development Denmark, Novo Nordisk, haemophilia API
Novo Nordisk has announced that the company is investing 500 million Danish kroner (about £48.8 million) in a new 19,000 …
Novo joins forces with MIT innovating drug devices
September 8, 2015Manufacturing and Production, Research and Development Novo Nordisk
Novo Nordisk has initiated a research collaboration with the Langer Laboratory at the Massachusetts Institute of Technology for what is …
Novo Nordisk to buy two pharma research companies
August 27, 2015Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, mergers and acquisitions
Novo Nordisk is to acquire two privately-held biopharmaceutical research companies specialising in diabetes, for undisclosed sums. Calibrium and MB2, formed …
Novo Nordisk plans $2bn expansion of production facilities
August 26, 2015Manufacturing and Production, Research and Development Novo Nordisk, manufacturing
Novo Nordisk will invest an estimated $2 billion over the next five years in new production facilities in the US, …
Novo Nordisk abandons Victoza submission after mixed T1D results
August 26, 2015Research and Development Novo Nordisk, Victoza, diabetes, insulin
Novo Nordisk has been forced to scrap plans to expand its licence for Victoza to include adults with type 1 …
Novo Nordisk pushes forward with new diabetes drug trial
July 13, 2015Research and Development GLP-1 agonist, Novo Nordisk, diabetes, phase III, semaglutide, type 2 diabetes
Novo Nordisk is taking the first steps towards adding another type 2 diabetes drug to its portfolio, after announcing positive …
Novo Nordisk pulls Tresiba in Germany after pricing row
July 6, 2015Manufacturing and Production, Sales and Marketing Drug pricing, Germany, Novo Nordisk, Reimbursement, Tresiba, market access
Novo Nordisk has discontinued its distribution of once-daily basal insulin Tresiba after pricing talks with the German body that represents …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
